

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.47774078 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.47774078 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.18664527 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.18664527 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.63471091 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.38183223 |
| 7 | tryptophan catabolic process (GO:0006569) | 5.87496557 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.87496557 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.87496557 |
| 10 | glyoxylate metabolic process (GO:0046487) | 5.83192197 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.76046382 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.72404764 |
| 13 | high-density lipoprotein particle remodeling (GO:0034375) | 5.66338080 |
| 14 | sulfur amino acid catabolic process (GO:0000098) | 5.60035966 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.53868870 |
| 16 | negative regulation of fibrinolysis (GO:0051918) | 5.48635805 |
| 17 | urea cycle (GO:0000050) | 5.45138981 |
| 18 | urea metabolic process (GO:0019627) | 5.45138981 |
| 19 | regulation of fibrinolysis (GO:0051917) | 5.25594575 |
| 20 | cysteine metabolic process (GO:0006534) | 5.24065113 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 5.21071308 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.07117863 |
| 23 | protein carboxylation (GO:0018214) | 5.07117863 |
| 24 | serine family amino acid catabolic process (GO:0009071) | 5.05808189 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 5.03925535 |
| 26 | aromatic amino acid family metabolic process (GO:0009072) | 5.03776358 |
| 27 | regulation of cholesterol esterification (GO:0010872) | 4.97623636 |
| 28 | regulation of triglyceride catabolic process (GO:0010896) | 4.95923278 |
| 29 | complement activation, alternative pathway (GO:0006957) | 4.92495281 |
| 30 | reverse cholesterol transport (GO:0043691) | 4.91717683 |
| 31 | regulation of protein activation cascade (GO:2000257) | 4.90702711 |
| 32 | bile acid metabolic process (GO:0008206) | 4.86468481 |
| 33 | bile acid and bile salt transport (GO:0015721) | 4.84216408 |
| 34 | protein-lipid complex remodeling (GO:0034368) | 4.80049390 |
| 35 | macromolecular complex remodeling (GO:0034367) | 4.80049390 |
| 36 | plasma lipoprotein particle remodeling (GO:0034369) | 4.80049390 |
| 37 | tyrosine metabolic process (GO:0006570) | 4.73260666 |
| 38 | indolalkylamine metabolic process (GO:0006586) | 4.72825702 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.70284213 |
| 40 | phospholipid efflux (GO:0033700) | 4.66300584 |
| 41 | negative regulation of sterol transport (GO:0032372) | 4.58655559 |
| 42 | negative regulation of cholesterol transport (GO:0032375) | 4.58655559 |
| 43 | acylglycerol homeostasis (GO:0055090) | 4.58207501 |
| 44 | triglyceride homeostasis (GO:0070328) | 4.58207501 |
| 45 | cellular glucuronidation (GO:0052695) | 4.57888992 |
| 46 | amino-acid betaine metabolic process (GO:0006577) | 4.57428720 |
| 47 | homocysteine metabolic process (GO:0050667) | 4.56618211 |
| 48 | regulation of complement activation (GO:0030449) | 4.56386357 |
| 49 | cellular ketone body metabolic process (GO:0046950) | 4.56380332 |
| 50 | alpha-amino acid catabolic process (GO:1901606) | 4.55198625 |
| 51 | lysine metabolic process (GO:0006553) | 4.46058189 |
| 52 | lysine catabolic process (GO:0006554) | 4.46058189 |
| 53 | plasma lipoprotein particle clearance (GO:0034381) | 4.40833875 |
| 54 | coenzyme catabolic process (GO:0009109) | 4.36397479 |
| 55 | imidazole-containing compound metabolic process (GO:0052803) | 4.31505840 |
| 56 | aldehyde catabolic process (GO:0046185) | 4.24022692 |
| 57 | cellular amino acid catabolic process (GO:0009063) | 4.23509357 |
| 58 | glycine metabolic process (GO:0006544) | 4.20484948 |
| 59 | NADH metabolic process (GO:0006734) | 4.17401090 |
| 60 | glucuronate metabolic process (GO:0019585) | 4.17120093 |
| 61 | uronic acid metabolic process (GO:0006063) | 4.17120093 |
| 62 | cholesterol efflux (GO:0033344) | 4.15074187 |
| 63 | arginine metabolic process (GO:0006525) | 4.10693097 |
| 64 | glutamate metabolic process (GO:0006536) | 4.10210136 |
| 65 | amine catabolic process (GO:0009310) | 4.08298538 |
| 66 | cellular biogenic amine catabolic process (GO:0042402) | 4.08298538 |
| 67 | ethanol oxidation (GO:0006069) | 4.07642267 |
| 68 | serine family amino acid metabolic process (GO:0009069) | 4.06402581 |
| 69 | benzene-containing compound metabolic process (GO:0042537) | 4.05415325 |
| 70 | drug catabolic process (GO:0042737) | 4.05149435 |
| 71 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.04743278 |
| 72 | cellular modified amino acid catabolic process (GO:0042219) | 4.01364226 |
| 73 | plasma lipoprotein particle assembly (GO:0034377) | 3.95323179 |
| 74 | ketone body metabolic process (GO:1902224) | 3.94509159 |
| 75 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.91781420 |
| 76 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.91781420 |
| 77 | fibrinolysis (GO:0042730) | 3.90948298 |
| 78 | negative regulation of lipase activity (GO:0060192) | 3.90343400 |
| 79 | serine family amino acid biosynthetic process (GO:0009070) | 3.86395734 |
| 80 | low-density lipoprotein particle remodeling (GO:0034374) | 3.83008782 |
| 81 | fructose metabolic process (GO:0006000) | 3.82057210 |
| 82 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.81992470 |
| 83 | positive regulation of lipid catabolic process (GO:0050996) | 3.80734220 |
| 84 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.76987402 |
| 85 | cofactor catabolic process (GO:0051187) | 3.75159066 |
| 86 | cholesterol homeostasis (GO:0042632) | 3.74179330 |
| 87 | organic acid catabolic process (GO:0016054) | 3.74058508 |
| 88 | carboxylic acid catabolic process (GO:0046395) | 3.74058508 |
| 89 | short-chain fatty acid metabolic process (GO:0046459) | 3.73918560 |
| 90 | blood coagulation, intrinsic pathway (GO:0007597) | 3.73652141 |
| 91 | sterol homeostasis (GO:0055092) | 3.68050150 |
| 92 | phospholipid homeostasis (GO:0055091) | 3.67181389 |
| 93 | acetyl-CoA metabolic process (GO:0006084) | 3.65776393 |
| 94 | flavonoid metabolic process (GO:0009812) | 3.62421441 |
| 95 | exogenous drug catabolic process (GO:0042738) | 3.61684223 |
| 96 | plasma lipoprotein particle organization (GO:0071827) | 3.59653776 |
| 97 | alkaloid metabolic process (GO:0009820) | 3.59255960 |
| 98 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.57805888 |
| 99 | response to nitrosative stress (GO:0051409) | 3.57250884 |
| 100 | acute-phase response (GO:0006953) | 3.54430155 |
| 101 | NAD biosynthetic process (GO:0009435) | 3.54197261 |
| 102 | protein-lipid complex assembly (GO:0065005) | 3.53128968 |
| 103 | lipoprotein metabolic process (GO:0042157) | 3.50079478 |
| 104 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.48697151 |
| 105 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.47715116 |
| 106 | ATP synthesis coupled proton transport (GO:0015986) | 3.47715116 |
| 107 | glycosphingolipid catabolic process (GO:0046479) | 3.38106462 |
| 108 | epoxygenase P450 pathway (GO:0019373) | 3.35491573 |
| 109 | oligosaccharide catabolic process (GO:0009313) | 3.35297779 |
| 110 | respiratory electron transport chain (GO:0022904) | 3.34524917 |
| 111 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.34501004 |
| 112 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.33841674 |
| 113 | electron transport chain (GO:0022900) | 3.25937110 |
| 114 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.15691917 |
| 115 | glycolipid catabolic process (GO:0019377) | 3.13330071 |
| 116 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.00419142 |
| 117 | deoxyribonucleotide catabolic process (GO:0009264) | 2.95718127 |
| 118 | deoxyribose phosphate catabolic process (GO:0046386) | 2.90954373 |
| 119 | oxidative phosphorylation (GO:0006119) | 2.90808563 |
| 120 | cytochrome complex assembly (GO:0017004) | 2.90195417 |
| 121 | vitamin biosynthetic process (GO:0009110) | 2.89614862 |
| 122 | protein complex biogenesis (GO:0070271) | 2.87930559 |
| 123 | L-ascorbic acid metabolic process (GO:0019852) | 2.86798608 |
| 124 | xenobiotic catabolic process (GO:0042178) | 2.86250019 |
| 125 | protein-lipid complex subunit organization (GO:0071825) | 2.85145988 |
| 126 | respiratory chain complex IV assembly (GO:0008535) | 2.84765546 |
| 127 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.83140753 |
| 128 | regulation of superoxide anion generation (GO:0032928) | 2.81116156 |
| 129 | chaperone-mediated protein transport (GO:0072321) | 2.79479174 |
| 130 | ceramide catabolic process (GO:0046514) | 2.76418142 |
| 131 | oxaloacetate metabolic process (GO:0006107) | 2.76041004 |
| 132 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.74585174 |
| 133 | GDP-mannose metabolic process (GO:0019673) | 2.73081111 |
| 134 | regulation of mitochondrial translation (GO:0070129) | 2.72749312 |
| 135 | regulation of lipoprotein particle clearance (GO:0010984) | 2.70881613 |
| 136 | aggressive behavior (GO:0002118) | 2.70400392 |
| 137 | autophagic vacuole fusion (GO:0000046) | 2.69607020 |
| 138 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.68879737 |
| 139 | base-excision repair, AP site formation (GO:0006285) | 2.66887030 |
| 140 | pentose metabolic process (GO:0019321) | 2.64477186 |
| 141 | mitochondrial calcium ion transport (GO:0006851) | 2.63180941 |
| 142 | drug metabolic process (GO:0017144) | 2.62528296 |
| 143 | angiotensin maturation (GO:0002003) | 2.53961635 |
| 144 | glutathione derivative biosynthetic process (GO:1901687) | 2.53745881 |
| 145 | glutathione derivative metabolic process (GO:1901685) | 2.53745881 |
| 146 | regulation of cholesterol storage (GO:0010885) | 2.53654766 |
| 147 | heme metabolic process (GO:0042168) | 2.52613360 |
| 148 | regulation of cholesterol transport (GO:0032374) | 2.51986471 |
| 149 | regulation of sterol transport (GO:0032371) | 2.51986471 |
| 150 | sphingolipid catabolic process (GO:0030149) | 2.51399690 |
| 151 | glutathione metabolic process (GO:0006749) | 2.50981760 |
| 152 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.50851443 |
| 153 | aerobic respiration (GO:0009060) | 2.47368752 |
| 154 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.45388049 |
| 155 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.44985523 |
| 156 | protein maturation by protein folding (GO:0022417) | 2.44700633 |
| 157 | heme transport (GO:0015886) | 2.44031620 |
| 158 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.43279896 |
| 159 | NADH dehydrogenase complex assembly (GO:0010257) | 2.43279896 |
| 160 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.43279896 |
| 161 | hydrogen ion transmembrane transport (GO:1902600) | 2.41623295 |
| 162 | immunoglobulin mediated immune response (GO:0016064) | 2.40371094 |
| 163 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.39286282 |
| 164 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.38844587 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.24506748 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.04664257 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.74773124 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.33028028 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.36046148 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.12512636 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.04578404 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.82339780 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.71309377 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.51334226 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.43528527 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.13804175 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.97010949 |
| 14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.87193826 |
| 15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.55179548 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.55069854 |
| 17 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.38428839 |
| 18 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.31667726 |
| 19 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.27616957 |
| 20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.25654709 |
| 21 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.22443365 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.21420305 |
| 23 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.20443377 |
| 24 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.04483661 |
| 25 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.03014341 |
| 26 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.00390900 |
| 27 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8788146 |
| 28 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.98116119 |
| 29 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.93962730 |
| 30 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.90866900 |
| 31 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.88515345 |
| 32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.75433683 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73378029 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.73047886 |
| 35 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.72598947 |
| 36 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.68630877 |
| 37 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.66062749 |
| 38 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.60537123 |
| 39 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.56489815 |
| 40 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.56434090 |
| 41 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.55484892 |
| 42 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.53786163 |
| 43 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.49738477 |
| 44 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.49274312 |
| 45 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.48460797 |
| 46 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.47092611 |
| 47 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.46999166 |
| 48 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.46806123 |
| 49 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.45850991 |
| 50 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.41901456 |
| 51 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.41230774 |
| 52 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 1.39982486 |
| 53 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.39917404 |
| 54 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.39560062 |
| 55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39248474 |
| 56 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.37462179 |
| 57 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36495996 |
| 58 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.36258805 |
| 59 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.34870194 |
| 60 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.33017945 |
| 61 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.31054399 |
| 62 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.29472674 |
| 63 | GATA1_22025678_ChIP-Seq_K562_Human | 1.28556666 |
| 64 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.27944775 |
| 65 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.24019132 |
| 66 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.22587529 |
| 67 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.22200571 |
| 68 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21897315 |
| 69 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.19052577 |
| 70 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18038786 |
| 71 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.17920274 |
| 72 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.17707792 |
| 73 | P68_20966046_ChIP-Seq_HELA_Human | 1.14846901 |
| 74 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.14703722 |
| 75 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.14147735 |
| 76 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12234395 |
| 77 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.10091830 |
| 78 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.08885761 |
| 79 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.07836285 |
| 80 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.07475410 |
| 81 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.07395718 |
| 82 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.07132053 |
| 83 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.06969491 |
| 84 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.04895791 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03564480 |
| 86 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02524475 |
| 87 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.01438030 |
| 88 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.00438640 |
| 89 | P300_27268052_Chip-Seq_Bcells_Human | 1.00091571 |
| 90 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99145267 |
| 91 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98955656 |
| 92 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.98728485 |
| 93 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97983924 |
| 94 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.97720791 |
| 95 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.97085064 |
| 96 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97041232 |
| 97 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.96468645 |
| 98 | SA1_27219007_Chip-Seq_Bcells_Human | 0.96450478 |
| 99 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.95420661 |
| 100 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.95062268 |
| 101 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.94634008 |
| 102 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.94593101 |
| 103 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.94439523 |
| 104 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.94039995 |
| 105 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.91537792 |
| 106 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.87731044 |
| 107 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.87532597 |
| 108 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.84387981 |
| 109 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.84228132 |
| 110 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.82493159 |
| 111 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.81820590 |
| 112 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.78991581 |
| 113 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.78821637 |
| 114 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.78674068 |
| 115 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.76395182 |
| 116 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.74897382 |
| 117 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.74547331 |
| 118 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73636778 |
| 119 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.73286573 |
| 120 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.73286573 |
| 121 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.71935483 |
| 122 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71176892 |
| 123 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.69694998 |
| 124 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.66610770 |
| 125 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.65654003 |
| 126 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.65286005 |
| 127 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.64842613 |
| 128 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.64620110 |
| 129 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.61310423 |
| 130 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.59448829 |
| 131 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.59433186 |
| 132 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.59429225 |
| 133 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.59129525 |
| 134 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.58398885 |
| 135 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.57869351 |
| 136 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.57669074 |
| 137 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.57124169 |
| 138 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.56309557 |
| 139 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.54591129 |
| 140 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.53893883 |
| 141 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.53343225 |
| 142 | AR_20517297_ChIP-Seq_VCAP_Human | 0.53037414 |
| 143 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.52361880 |
| 144 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.51562183 |
| 145 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50904056 |
| 146 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50843108 |
| 147 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47904973 |
| 148 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.47736470 |
| 149 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.46703478 |
| 150 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.46450040 |
| 151 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.45380131 |
| 152 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.44798899 |
| 153 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.44678154 |
| 154 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.44240290 |
| 155 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.42984456 |
| 156 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.42766795 |
| 157 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.42054197 |
| 158 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.41894841 |
| 159 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.41392117 |
| 160 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.41298999 |
| 161 | CBP_21632823_ChIP-Seq_H3396_Human | 0.41137369 |
| 162 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.41071883 |
| 163 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.40612741 |
| 164 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.39446699 |
| 165 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.39302739 |
| 166 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.39107958 |
| 167 | NCOR_22424771_ChIP-Seq_293T_Human | 0.38700841 |
| 168 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.38661767 |
| 169 | GATA2_19941826_ChIP-Seq_K562_Human | 0.38618541 |
| 170 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.38106540 |
| 171 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.38017128 |
| 172 | GATA1_19941826_ChIP-Seq_K562_Human | 0.37578097 |
| 173 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.37570284 |
| 174 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.37563116 |
| 175 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.37374861 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.17036508 |
| 2 | MP0005360_urolithiasis | 7.64493307 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.24239625 |
| 4 | MP0005365_abnormal_bile_salt | 5.99365112 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.33499596 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.32677442 |
| 7 | MP0003252_abnormal_bile_duct | 3.79453999 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.59874538 |
| 9 | MP0009840_abnormal_foam_cell | 3.22628316 |
| 10 | MP0005083_abnormal_biliary_tract | 2.95722748 |
| 11 | MP0005332_abnormal_amino_acid | 2.86506002 |
| 12 | MP0003195_calcinosis | 2.80133917 |
| 13 | MP0005058_abnormal_lysosome_morphology | 2.75434558 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.51498490 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.39528036 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.12048878 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.09899638 |
| 18 | MP0000609_abnormal_liver_physiology | 2.07628278 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.95468428 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.87350955 |
| 21 | MP0003868_abnormal_feces_composition | 1.76672709 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 1.74159482 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 1.73316493 |
| 24 | MP0001764_abnormal_homeostasis | 1.72366325 |
| 25 | MP0009697_abnormal_copulation | 1.62369368 |
| 26 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57930003 |
| 27 | MP0005671_abnormal_response_to | 1.54313964 |
| 28 | MP0001835_abnormal_antigen_presentation | 1.51178291 |
| 29 | MP0005451_abnormal_body_composition | 1.47438396 |
| 30 | MP0010234_abnormal_vibrissa_follicle | 1.47427014 |
| 31 | MP0003186_abnormal_redox_activity | 1.42305651 |
| 32 | MP0010386_abnormal_urinary_bladder | 1.40152876 |
| 33 | MP0009785_altered_susceptibility_to | 1.39834265 |
| 34 | MP0001986_abnormal_taste_sensitivity | 1.39281690 |
| 35 | MP0003011_delayed_dark_adaptation | 1.36047999 |
| 36 | MP0009643_abnormal_urine_homeostasis | 1.35633804 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 1.35259329 |
| 38 | MP0005025_abnormal_response_to | 1.30477541 |
| 39 | MP0002419_abnormal_innate_immunity | 1.29749979 |
| 40 | MP0004147_increased_porphyrin_level | 1.26710944 |
| 41 | MP0001545_abnormal_hematopoietic_system | 1.24436498 |
| 42 | MP0005397_hematopoietic_system_phenotyp | 1.24436498 |
| 43 | MP0000604_amyloidosis | 1.19257342 |
| 44 | MP0005645_abnormal_hypothalamus_physiol | 1.16904789 |
| 45 | MP0000598_abnormal_liver_morphology | 1.15168842 |
| 46 | MP0002452_abnormal_antigen_presenting | 1.14762287 |
| 47 | MP0003656_abnormal_erythrocyte_physiolo | 1.13772512 |
| 48 | MP0005000_abnormal_immune_tolerance | 1.13480635 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.12951295 |
| 50 | MP0005387_immune_system_phenotype | 1.05648290 |
| 51 | MP0001790_abnormal_immune_system | 1.05648290 |
| 52 | MP0002723_abnormal_immune_serum | 1.03960931 |
| 53 | MP0003436_decreased_susceptibility_to | 1.03408645 |
| 54 | MP0010368_abnormal_lymphatic_system | 1.03177813 |
| 55 | MP0010155_abnormal_intestine_physiology | 1.02821764 |
| 56 | MP0005410_abnormal_fertilization | 1.02664520 |
| 57 | MP0005647_abnormal_sex_gland | 1.02085669 |
| 58 | MP0000343_altered_response_to | 1.01175930 |
| 59 | MP0003693_abnormal_embryo_hatching | 0.97947400 |
| 60 | MP0001800_abnormal_humoral_immune | 0.97900150 |
| 61 | MP0005636_abnormal_mineral_homeostasis | 0.97881083 |
| 62 | MP0005084_abnormal_gallbladder_morpholo | 0.96227423 |
| 63 | MP0000685_abnormal_immune_system | 0.95855650 |
| 64 | MP0009764_decreased_sensitivity_to | 0.94956414 |
| 65 | MP0005670_abnormal_white_adipose | 0.94762503 |
| 66 | MP0003879_abnormal_hair_cell | 0.94760674 |
| 67 | MP0002090_abnormal_vision | 0.94567869 |
| 68 | MP0002420_abnormal_adaptive_immunity | 0.94277107 |
| 69 | MP0001819_abnormal_immune_cell | 0.94047955 |
| 70 | MP0009278_abnormal_bone_marrow | 0.93930378 |
| 71 | MP0006036_abnormal_mitochondrial_physio | 0.92454584 |
| 72 | MP0009763_increased_sensitivity_to | 0.92258688 |
| 73 | MP0002876_abnormal_thyroid_physiology | 0.90851516 |
| 74 | MP0009642_abnormal_blood_homeostasis | 0.89903864 |
| 75 | MP0003172_abnormal_lysosome_physiology | 0.88021215 |
| 76 | MP0000490_abnormal_crypts_of | 0.87598746 |
| 77 | MP0005376_homeostasis/metabolism_phenot | 0.85926343 |
| 78 | MP0003303_peritoneal_inflammation | 0.84638107 |
| 79 | MP0008469_abnormal_protein_level | 0.83331447 |
| 80 | MP0005408_hypopigmentation | 0.83171283 |
| 81 | MP0003786_premature_aging | 0.81870875 |
| 82 | MP0000465_gastrointestinal_hemorrhage | 0.80621967 |
| 83 | MP0000689_abnormal_spleen_morphology | 0.79674285 |
| 84 | MP0005535_abnormal_body_temperature | 0.79665550 |
| 85 | MP0004742_abnormal_vestibular_system | 0.79419717 |
| 86 | MP0009053_abnormal_anal_canal | 0.78906221 |
| 87 | MP0001727_abnormal_embryo_implantation | 0.78444684 |
| 88 | MP0009046_muscle_twitch | 0.77741863 |
| 89 | MP0002254_reproductive_system_inflammat | 0.77174891 |
| 90 | MP0001984_abnormal_olfaction | 0.76869380 |
| 91 | MP0002078_abnormal_glucose_homeostasis | 0.76617757 |
| 92 | MP0002971_abnormal_brown_adipose | 0.76606509 |
| 93 | MP0005379_endocrine/exocrine_gland_phen | 0.75884184 |
| 94 | MP0000358_abnormal_cell_content/ | 0.75579398 |
| 95 | MP0005075_abnormal_melanosome_morpholog | 0.74384078 |
| 96 | MP0003866_abnormal_defecation | 0.73401231 |
| 97 | MP0005266_abnormal_metabolism | 0.73129190 |
| 98 | MP0002837_dystrophic_cardiac_calcinosis | 0.71401843 |
| 99 | MP0002277_abnormal_respiratory_mucosa | 0.70538920 |
| 100 | MP0001873_stomach_inflammation | 0.70319702 |
| 101 | MP0008260_abnormal_autophagy | 0.69793989 |
| 102 | MP0003329_amyloid_beta_deposits | 0.68977875 |
| 103 | MP0000716_abnormal_immune_system | 0.68273599 |
| 104 | MP0001756_abnormal_urination | 0.68253830 |
| 105 | MP0009765_abnormal_xenobiotic_induced | 0.65997720 |
| 106 | MP0005334_abnormal_fat_pad | 0.64478321 |
| 107 | MP0004130_abnormal_muscle_cell | 0.64380709 |
| 108 | MP0006035_abnormal_mitochondrial_morpho | 0.59316541 |
| 109 | MP0005220_abnormal_exocrine_pancreas | 0.58700955 |
| 110 | MP0000639_abnormal_adrenal_gland | 0.57221367 |
| 111 | MP0003690_abnormal_glial_cell | 0.53126686 |
| 112 | MP0005448_abnormal_energy_balance | 0.51548879 |
| 113 | MP0002136_abnormal_kidney_physiology | 0.50152508 |
| 114 | MP0003953_abnormal_hormone_level | 0.46861560 |
| 115 | MP0005395_other_phenotype | 0.46836690 |
| 116 | MP0008873_increased_physiological_sensi | 0.44554113 |
| 117 | MP0003638_abnormal_response/metabolism_ | 0.44209389 |
| 118 | MP0002822_catalepsy | 0.43989807 |
| 119 | MP0004782_abnormal_surfactant_physiolog | 0.43708462 |
| 120 | MP0008874_decreased_physiological_sensi | 0.43618053 |
| 121 | MP0000230_abnormal_systemic_arterial | 0.43237979 |
| 122 | MP0004883_abnormal_blood_vessel | 0.43060350 |
| 123 | MP0005666_abnormal_adipose_tissue | 0.42588633 |
| 124 | MP0002796_impaired_skin_barrier | 0.42060563 |
| 125 | MP0001661_extended_life_span | 0.40828073 |
| 126 | MP0003718_maternal_effect | 0.40338859 |
| 127 | MP0005464_abnormal_platelet_physiology | 0.39608071 |
| 128 | MP0005248_abnormal_Harderian_gland | 0.38324461 |
| 129 | MP0008872_abnormal_physiological_respon | 0.38158582 |
| 130 | MP0000249_abnormal_blood_vessel | 0.36508702 |
| 131 | MP0003075_altered_response_to | 0.36294876 |
| 132 | MP0009672_abnormal_birth_weight | 0.36023469 |
| 133 | MP0003724_increased_susceptibility_to | 0.35096874 |
| 134 | MP0002132_abnormal_respiratory_system | 0.35002766 |
| 135 | MP0002928_abnormal_bile_duct | 0.34301557 |
| 136 | MP0005166_decreased_susceptibility_to | 0.33736396 |
| 137 | MP0001243_abnormal_dermal_layer | 0.32923524 |
| 138 | MP0009115_abnormal_fat_cell | 0.32594165 |
| 139 | MP0002970_abnormal_white_adipose | 0.32305271 |
| 140 | MP0002168_other_aberrant_phenotype | 0.32251095 |
| 141 | MP0005167_abnormal_blood-brain_barrier | 0.31617263 |
| 142 | MP0005164_abnormal_response_to | 0.31271398 |
| 143 | MP0005330_cardiomyopathy | 0.31200545 |
| 144 | MP0004043_abnormal_pH_regulation | 0.27565435 |
| 145 | MP0009379_abnormal_foot_pigmentation | 0.26908598 |
| 146 | MP0006082_CNS_inflammation | 0.26584346 |
| 147 | MP0006276_abnormal_autonomic_nervous | 0.26570789 |
| 148 | MP0002135_abnormal_kidney_morphology | 0.25728039 |
| 149 | MP0001853_heart_inflammation | 0.25464377 |
| 150 | MP0001881_abnormal_mammary_gland | 0.24647549 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.63970440 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.21643282 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.88981086 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.47424291 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.27439539 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.20364957 |
| 7 | Xanthomatosis (HP:0000991) | 6.19133534 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.60725147 |
| 9 | Complement deficiency (HP:0004431) | 4.86693498 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.76991417 |
| 11 | Hyperammonemia (HP:0001987) | 4.57561392 |
| 12 | Joint hemorrhage (HP:0005261) | 4.54415191 |
| 13 | Ketosis (HP:0001946) | 4.34866508 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.34602788 |
| 15 | Hyperglycinemia (HP:0002154) | 4.30216469 |
| 16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.26763866 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 4.26009336 |
| 18 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.21254248 |
| 19 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.21254248 |
| 20 | Abnormality of glycolipid metabolism (HP:0010969) | 4.21254248 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 4.20148304 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.18848975 |
| 23 | Epidermoid cyst (HP:0200040) | 4.17030541 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.15858230 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 4.09231374 |
| 26 | Hyperglycinuria (HP:0003108) | 4.07050806 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.96952936 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.96952936 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.92865030 |
| 30 | Vacuolated lymphocytes (HP:0001922) | 3.89822868 |
| 31 | Fat malabsorption (HP:0002630) | 3.88249631 |
| 32 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.84344072 |
| 33 | Acute necrotizing encephalopathy (HP:0006965) | 3.77153261 |
| 34 | Mitochondrial inheritance (HP:0001427) | 3.68977586 |
| 35 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.67591188 |
| 36 | Acute encephalopathy (HP:0006846) | 3.66123052 |
| 37 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.63326305 |
| 38 | Abnormality of complement system (HP:0005339) | 3.56068195 |
| 39 | Hypercholesterolemia (HP:0003124) | 3.54080372 |
| 40 | Abnormality of the intrinsic pathway (HP:0010989) | 3.51604822 |
| 41 | Hepatocellular necrosis (HP:0001404) | 3.44101661 |
| 42 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.41106971 |
| 43 | Nausea (HP:0002018) | 3.40757680 |
| 44 | Hepatic necrosis (HP:0002605) | 3.39109271 |
| 45 | Increased intramyocellular lipid droplets (HP:0012240) | 3.34474449 |
| 46 | Increased CSF lactate (HP:0002490) | 3.31431212 |
| 47 | Increased muscle lipid content (HP:0009058) | 3.29783688 |
| 48 | Hyperbilirubinemia (HP:0002904) | 3.24859641 |
| 49 | Conjugated hyperbilirubinemia (HP:0002908) | 3.19996030 |
| 50 | Ketoacidosis (HP:0001993) | 3.16999666 |
| 51 | Delayed CNS myelination (HP:0002188) | 3.11476253 |
| 52 | Lipid accumulation in hepatocytes (HP:0006561) | 3.03063142 |
| 53 | Renal Fanconi syndrome (HP:0001994) | 3.02949499 |
| 54 | Spontaneous abortion (HP:0005268) | 3.02947253 |
| 55 | Abnormality of nucleobase metabolism (HP:0010932) | 3.02194180 |
| 56 | Progressive macrocephaly (HP:0004481) | 3.01587504 |
| 57 | Abnormality of serum amino acid levels (HP:0003112) | 2.97429240 |
| 58 | Hepatocellular carcinoma (HP:0001402) | 2.94874719 |
| 59 | Increased hepatocellular lipid droplets (HP:0006565) | 2.94786559 |
| 60 | Steatorrhea (HP:0002570) | 2.93257979 |
| 61 | Metabolic acidosis (HP:0001942) | 2.84397106 |
| 62 | Lethargy (HP:0001254) | 2.81810576 |
| 63 | Dicarboxylic aciduria (HP:0003215) | 2.80055433 |
| 64 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.80055433 |
| 65 | Cerebral edema (HP:0002181) | 2.78515968 |
| 66 | Myocardial infarction (HP:0001658) | 2.72926281 |
| 67 | Abnormality of purine metabolism (HP:0004352) | 2.69495675 |
| 68 | Increased cerebral lipofuscin (HP:0011813) | 2.68499413 |
| 69 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.67623792 |
| 70 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.67623792 |
| 71 | Skin nodule (HP:0200036) | 2.66771736 |
| 72 | Abnormality of macrophages (HP:0004311) | 2.62527191 |
| 73 | Gout (HP:0001997) | 2.60910513 |
| 74 | Hypochromic microcytic anemia (HP:0004840) | 2.58945509 |
| 75 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.55243832 |
| 76 | Lactic acidosis (HP:0003128) | 2.55155021 |
| 77 | Petechiae (HP:0000967) | 2.51371497 |
| 78 | Reduced antithrombin III activity (HP:0001976) | 2.51341483 |
| 79 | Systemic lupus erythematosus (HP:0002725) | 2.49144821 |
| 80 | Vascular calcification (HP:0004934) | 2.49123047 |
| 81 | Irritability (HP:0000737) | 2.48708207 |
| 82 | Neonatal onset (HP:0003623) | 2.47891775 |
| 83 | Malnutrition (HP:0004395) | 2.44240618 |
| 84 | Respiratory failure (HP:0002878) | 2.44125885 |
| 85 | Glomerulonephritis (HP:0000099) | 2.41254183 |
| 86 | Retinal atrophy (HP:0001105) | 2.36036076 |
| 87 | Abnormal gallbladder morphology (HP:0012437) | 2.34325461 |
| 88 | Mitral stenosis (HP:0001718) | 2.33207816 |
| 89 | Methylmalonic aciduria (HP:0012120) | 2.32827240 |
| 90 | Cholecystitis (HP:0001082) | 2.31871544 |
| 91 | Abnormal gallbladder physiology (HP:0012438) | 2.31871544 |
| 92 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.31825830 |
| 93 | Generalized aminoaciduria (HP:0002909) | 2.31179948 |
| 94 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.30105053 |
| 95 | Cholelithiasis (HP:0001081) | 2.29943556 |
| 96 | Amyloidosis (HP:0011034) | 2.29671791 |
| 97 | Spastic diplegia (HP:0001264) | 2.29498025 |
| 98 | Purpura (HP:0000979) | 2.28836298 |
| 99 | Multiple enchondromatosis (HP:0005701) | 2.28527547 |
| 100 | Hypoglycemic seizures (HP:0002173) | 2.27919264 |
| 101 | Increased serum ferritin (HP:0003281) | 2.26250000 |
| 102 | Vomiting (HP:0002013) | 2.26175926 |
| 103 | Esophageal varix (HP:0002040) | 2.23799970 |
| 104 | Sensorimotor neuropathy (HP:0007141) | 2.23425623 |
| 105 | Cardiovascular calcification (HP:0011915) | 2.22685338 |
| 106 | Increased serum lactate (HP:0002151) | 2.21628923 |
| 107 | Brushfield spots (HP:0001088) | 2.18817076 |
| 108 | Enlarged kidneys (HP:0000105) | 2.18261606 |
| 109 | Late onset (HP:0003584) | 2.16350012 |
| 110 | Pancreatitis (HP:0001733) | 2.15876935 |
| 111 | Cerebral palsy (HP:0100021) | 2.13659812 |
| 112 | Acanthocytosis (HP:0001927) | 2.12854786 |
| 113 | Exertional dyspnea (HP:0002875) | 2.11896016 |
| 114 | Chronic obstructive pulmonary disease (HP:0006510) | 2.09615403 |
| 115 | Obstructive lung disease (HP:0006536) | 2.09615403 |
| 116 | CNS demyelination (HP:0007305) | 2.09507150 |
| 117 | Hyperphosphaturia (HP:0003109) | 2.08717047 |
| 118 | Exercise intolerance (HP:0003546) | 2.07634350 |
| 119 | Loss of speech (HP:0002371) | 2.07243350 |
| 120 | Menorrhagia (HP:0000132) | 2.06950688 |
| 121 | Type I transferrin isoform profile (HP:0003642) | 2.05370855 |
| 122 | Thrombophlebitis (HP:0004418) | 2.04617227 |
| 123 | Progressive neurologic deterioration (HP:0002344) | 2.03743545 |
| 124 | Recurrent abscess formation (HP:0002722) | 2.01928035 |
| 125 | Gingival bleeding (HP:0000225) | 2.01783363 |
| 126 | Alkalosis (HP:0001948) | 2.01003019 |
| 127 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.97514260 |
| 128 | Eczematoid dermatitis (HP:0000976) | 1.97155758 |
| 129 | Respiratory difficulties (HP:0002880) | 1.97118925 |
| 130 | Opisthotonus (HP:0002179) | 1.96763443 |
| 131 | Proximal tubulopathy (HP:0000114) | 1.95738641 |
| 132 | Abnormal cartilage morphology (HP:0002763) | 1.95723676 |
| 133 | Abnormality of proline metabolism (HP:0010907) | 1.94686344 |
| 134 | Hydroxyprolinuria (HP:0003080) | 1.94686344 |
| 135 | Abnormality of urine glucose concentration (HP:0011016) | 1.93422759 |
| 136 | Glycosuria (HP:0003076) | 1.93422759 |
| 137 | Hepatosplenomegaly (HP:0001433) | 1.93142998 |
| 138 | Rickets (HP:0002748) | 1.92521096 |
| 139 | Abnormality of the gallbladder (HP:0005264) | 1.91733520 |
| 140 | 3-Methylglutaconic aciduria (HP:0003535) | 1.90647584 |
| 141 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.90541843 |
| 142 | Increased serum pyruvate (HP:0003542) | 1.90170454 |
| 143 | Hypophosphatemic rickets (HP:0004912) | 1.89710362 |
| 144 | Emotional lability (HP:0000712) | 1.88585330 |
| 145 | Prolonged neonatal jaundice (HP:0006579) | 1.88452342 |
| 146 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.88434602 |
| 147 | Renal cortical cysts (HP:0000803) | 1.88392616 |
| 148 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.87796620 |
| 149 | Hemorrhage of the eye (HP:0011885) | 1.84845367 |
| 150 | Ragged-red muscle fibers (HP:0003200) | 1.84282404 |
| 151 | Dysphonia (HP:0001618) | 1.82632129 |
| 152 | Dysostosis multiplex (HP:0000943) | 1.81888936 |
| 153 | Poikilocytosis (HP:0004447) | 1.81223016 |
| 154 | Status epilepticus (HP:0002133) | 1.80395695 |
| 155 | Hyperuricemia (HP:0002149) | 1.77572660 |
| 156 | Increased purine levels (HP:0004368) | 1.77572660 |
| 157 | Abnormality of iron homeostasis (HP:0011031) | 1.77511284 |
| 158 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.77357470 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.59130907 |
| 2 | SIK1 | 4.41659846 |
| 3 | MAP3K12 | 4.08547440 |
| 4 | FGFR4 | 4.08224268 |
| 5 | ERN1 | 4.03798143 |
| 6 | TESK2 | 3.46994941 |
| 7 | INSRR | 2.66903023 |
| 8 | PIM2 | 2.49510661 |
| 9 | MAP4K1 | 2.48945259 |
| 10 | PIK3CA | 2.44935796 |
| 11 | ERBB4 | 2.36671791 |
| 12 | VRK2 | 2.36169963 |
| 13 | PKN2 | 2.34893066 |
| 14 | ARAF | 2.28778514 |
| 15 | PDK2 | 2.28108762 |
| 16 | STK16 | 2.27587953 |
| 17 | MAP2K4 | 2.21459110 |
| 18 | TESK1 | 2.17711190 |
| 19 | TAOK3 | 2.05893630 |
| 20 | SCYL2 | 2.01921156 |
| 21 | MST1R | 2.01481291 |
| 22 | ACVR1B | 1.94461891 |
| 23 | RIPK1 | 1.91407265 |
| 24 | TRIB3 | 1.90216824 |
| 25 | ZAK | 1.83655584 |
| 26 | FRK | 1.74976781 |
| 27 | TXK | 1.74144774 |
| 28 | ABL2 | 1.70365266 |
| 29 | PIK3CG | 1.68580154 |
| 30 | KDR | 1.64257450 |
| 31 | MST4 | 1.56781484 |
| 32 | NME1 | 1.54148611 |
| 33 | TLK1 | 1.53500433 |
| 34 | MAP2K3 | 1.53399190 |
| 35 | MAP3K3 | 1.53080738 |
| 36 | MAPK11 | 1.49711750 |
| 37 | FLT3 | 1.46648799 |
| 38 | BUB1 | 1.40697317 |
| 39 | GRK6 | 1.39622131 |
| 40 | TIE1 | 1.35379700 |
| 41 | MAP3K11 | 1.29371361 |
| 42 | IRAK3 | 1.29068535 |
| 43 | PTK6 | 1.28365913 |
| 44 | TAOK2 | 1.27755515 |
| 45 | GRK5 | 1.27170269 |
| 46 | DAPK2 | 1.26187556 |
| 47 | MAPK15 | 1.25882489 |
| 48 | MAP3K14 | 1.25824177 |
| 49 | MAP4K2 | 1.20925116 |
| 50 | TYK2 | 1.17166838 |
| 51 | GRK7 | 1.10723634 |
| 52 | MYLK | 1.10602878 |
| 53 | MAPK4 | 1.10411956 |
| 54 | DAPK1 | 1.08699885 |
| 55 | PINK1 | 1.07389121 |
| 56 | MUSK | 1.05011731 |
| 57 | LATS1 | 1.04751415 |
| 58 | IKBKB | 1.03572083 |
| 59 | BRAF | 1.01595702 |
| 60 | CDK19 | 1.00174920 |
| 61 | PRKCZ | 0.94545914 |
| 62 | PBK | 0.92826684 |
| 63 | TBK1 | 0.92138604 |
| 64 | BLK | 0.91201732 |
| 65 | PRKAA2 | 0.90944392 |
| 66 | RPS6KA5 | 0.88397919 |
| 67 | MAP3K7 | 0.88357407 |
| 68 | CAMK2G | 0.88318986 |
| 69 | NEK9 | 0.87712971 |
| 70 | STK38L | 0.87131468 |
| 71 | PIM1 | 0.86029847 |
| 72 | CSNK1G1 | 0.85718574 |
| 73 | MAP2K6 | 0.85304806 |
| 74 | FES | 0.84912623 |
| 75 | VRK1 | 0.84912052 |
| 76 | JAK2 | 0.84070147 |
| 77 | PTK2 | 0.82136229 |
| 78 | MAP2K2 | 0.81635176 |
| 79 | ILK | 0.79800221 |
| 80 | CSNK1A1L | 0.78589001 |
| 81 | PRKACG | 0.76467698 |
| 82 | MAPK12 | 0.75814770 |
| 83 | NUAK1 | 0.75646662 |
| 84 | GSK3A | 0.75427572 |
| 85 | DYRK1B | 0.74231987 |
| 86 | EPHB2 | 0.72092954 |
| 87 | SYK | 0.71008397 |
| 88 | CDC7 | 0.70543203 |
| 89 | ERBB2 | 0.70122791 |
| 90 | LATS2 | 0.68898828 |
| 91 | EIF2AK1 | 0.68572057 |
| 92 | CSNK1G3 | 0.67985613 |
| 93 | PAK4 | 0.67705965 |
| 94 | LRRK2 | 0.67586964 |
| 95 | LYN | 0.66902377 |
| 96 | EIF2AK3 | 0.66003519 |
| 97 | LMTK2 | 0.62211361 |
| 98 | LIMK1 | 0.62187650 |
| 99 | SGK3 | 0.61856760 |
| 100 | TTK | 0.61717743 |
| 101 | KIT | 0.61669263 |
| 102 | JAK1 | 0.60551281 |
| 103 | PRKCI | 0.60200134 |
| 104 | CSNK1G2 | 0.57930828 |
| 105 | AURKA | 0.57837670 |
| 106 | MAP2K1 | 0.57777643 |
| 107 | TGFBR2 | 0.57624274 |
| 108 | CSNK2A1 | 0.57352207 |
| 109 | FGFR2 | 0.56218991 |
| 110 | ITK | 0.55815771 |
| 111 | PDK1 | 0.55443743 |
| 112 | STK10 | 0.55388021 |
| 113 | PRKCQ | 0.55265838 |
| 114 | MET | 0.55045729 |
| 115 | PRKCG | 0.54666246 |
| 116 | CDK6 | 0.53380978 |
| 117 | NEK1 | 0.53189143 |
| 118 | GRK1 | 0.51801144 |
| 119 | PRKAA1 | 0.50855437 |
| 120 | SMG1 | 0.50507418 |
| 121 | BTK | 0.49964471 |
| 122 | MATK | 0.49749675 |
| 123 | ADRBK2 | 0.49254619 |
| 124 | RIPK4 | 0.48064762 |
| 125 | CSNK2A2 | 0.46772937 |
| 126 | JAK3 | 0.46715818 |
| 127 | SGK494 | 0.46655249 |
| 128 | SGK223 | 0.46655249 |
| 129 | PAK3 | 0.46646519 |
| 130 | OBSCN | 0.46290354 |
| 131 | LCK | 0.45736827 |
| 132 | EPHB1 | 0.45055031 |
| 133 | EPHA2 | 0.45043244 |
| 134 | PDPK1 | 0.44859063 |
| 135 | SGK2 | 0.44522080 |
| 136 | TEC | 0.43056093 |
| 137 | CSK | 0.42689219 |
| 138 | MAP3K5 | 0.42618663 |
| 139 | TAOK1 | 0.42614561 |
| 140 | MAPK7 | 0.41963522 |
| 141 | PRKCD | 0.41597829 |
| 142 | PRKCA | 0.38971941 |
| 143 | DAPK3 | 0.38536922 |
| 144 | MAP3K10 | 0.38327392 |
| 145 | TNK2 | 0.38105688 |
| 146 | CAMKK2 | 0.38031808 |
| 147 | IKBKE | 0.37662224 |
| 148 | MAP3K8 | 0.37393388 |
| 149 | IGF1R | 0.33843896 |
| 150 | CAMK2D | 0.30790011 |
| 151 | MAP3K2 | 0.30045842 |
| 152 | NME2 | 0.30027745 |
| 153 | EPHA3 | 0.29114274 |
| 154 | PRKACA | 0.26961430 |
| 155 | CAMK2A | 0.24684097 |
| 156 | RET | 0.24459699 |
| 157 | CAMK1D | 0.23192414 |
| 158 | CSF1R | 0.22913045 |
| 159 | MAP3K1 | 0.22789511 |
| 160 | PRKG2 | 0.21935873 |
| 161 | CSNK1E | 0.21702359 |
| 162 | EGFR | 0.21545629 |
| 163 | MAPK3 | 0.19041748 |
| 164 | PRKACB | 0.19038016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.30344660 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.39483933 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.24442207 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.11062511 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.98298467 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.79185324 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.61552388 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.58221753 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.57972641 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.50176749 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.46410187 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.39578005 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.38642559 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.28776175 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.23044105 |
| 16 | Proteasome_Homo sapiens_hsa03050 | 2.07976962 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.07397331 |
| 18 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.06512367 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.05119759 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 2.04058078 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.96798581 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.96763363 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.85746128 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.85666522 |
| 25 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.84801747 |
| 26 | Ribosome_Homo sapiens_hsa03010 | 1.84254498 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.83648263 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.83543428 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.76599668 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.74147709 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73567135 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.71578237 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.68697751 |
| 34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.67758250 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.64071845 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.60593887 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.59180850 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.54628045 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.54421026 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.53392211 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47177724 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38908781 |
| 43 | Huntingtons disease_Homo sapiens_hsa05016 | 1.38230874 |
| 44 | Asthma_Homo sapiens_hsa05310 | 1.36484500 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.34668805 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33004685 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31976651 |
| 48 | Lysosome_Homo sapiens_hsa04142 | 1.31848203 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.28619275 |
| 50 | Sulfur relay system_Homo sapiens_hsa04122 | 1.20236244 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19082238 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18395362 |
| 53 | DNA replication_Homo sapiens_hsa03030 | 1.18107795 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15635292 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15348789 |
| 56 | Base excision repair_Homo sapiens_hsa03410 | 1.06018947 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 1.03656243 |
| 58 | Mismatch repair_Homo sapiens_hsa03430 | 1.02670972 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.01502499 |
| 60 | Allograft rejection_Homo sapiens_hsa05330 | 1.00392244 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00081232 |
| 62 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.95847177 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93449209 |
| 64 | RNA polymerase_Homo sapiens_hsa03020 | 0.93407163 |
| 65 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.93251726 |
| 66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.93241587 |
| 67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.92061135 |
| 68 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.89801854 |
| 69 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.89112811 |
| 70 | Mineral absorption_Homo sapiens_hsa04978 | 0.88300654 |
| 71 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.88050799 |
| 72 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.86178628 |
| 73 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.85800347 |
| 74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.85536207 |
| 75 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.85259150 |
| 76 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.83724074 |
| 77 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.80686154 |
| 78 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.80541155 |
| 79 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.79878664 |
| 80 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.78649510 |
| 81 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.73135290 |
| 82 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73093659 |
| 83 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71095211 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67722774 |
| 85 | Lysine degradation_Homo sapiens_hsa00310 | 0.66602634 |
| 86 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.61267724 |
| 87 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.59955729 |
| 88 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.57133670 |
| 89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56313292 |
| 90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54577033 |
| 91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53730370 |
| 92 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52066048 |
| 93 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.51481095 |
| 94 | Homologous recombination_Homo sapiens_hsa03440 | 0.46765090 |
| 95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.46645114 |
| 96 | Purine metabolism_Homo sapiens_hsa00230 | 0.46354737 |
| 97 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41130628 |
| 98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38248133 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.32715564 |
| 100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31243964 |
| 101 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.23933404 |
| 102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20793052 |
| 103 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20661316 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.19037729 |
| 105 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.18763611 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17070325 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11465899 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07869154 |
| 109 | Amoebiasis_Homo sapiens_hsa05146 | -0.2441387 |
| 110 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2383654 |
| 111 | Bladder cancer_Homo sapiens_hsa05219 | -0.2368580 |
| 112 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.2203140 |
| 113 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1948904 |
| 114 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1913849 |
| 115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1879727 |
| 116 | Hepatitis C_Homo sapiens_hsa05160 | -0.1835452 |
| 117 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1558695 |
| 118 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1515969 |
| 119 | Alzheimers disease_Homo sapiens_hsa05010 | -0.1249801 |
| 120 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1192559 |
| 121 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1106662 |
| 122 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1087400 |
| 123 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0990660 |
| 124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0940677 |
| 125 | Parkinsons disease_Homo sapiens_hsa05012 | -0.0370110 |
| 126 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0271745 |
| 127 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0145676 |
| 128 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0050033 |
| 129 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.0040345 |

